NCT06850675

Brief Summary

Abstract Aim: To compare the clinical performance and pharyngolaryngeal complications of two second-generation, supraglottic airway devices (SGAD), the I-gel and Laryngeal Mask Airway-Supreme (LMA-Supreme), in geriatric patients undergoing elective surgery under general anesthesia. Materials and Methods: After hospital ethics committee approval (19-4.1T/40- 17.04.2019) and written informed consent, patients aged 65 years and older, with an American Society of Anesthesiologists score of I-III, and who were scheduled for elective urological surgery under general anesthesia, were included prospectively. The patients were randomly divided into two equal sized groups, I-gel and LMA-supreme. The two groups were evaluated and compared for ease of supraglottic airway device insertion, time of insertion, success rate at first insertion, number of attempts, ease of gastric tube insertion, oropharyngeal leak pressure, and intraoperative and postoperative complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 17, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2020

Completed
4.7 years until next milestone

First Submitted

Initial submission to the registry

February 13, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 27, 2025

Completed
Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

1 year

First QC Date

February 13, 2025

Last Update Submit

February 21, 2025

Conditions

Keywords

supraglottic airway deviceI-gelLMA-Supremegeriatric patientsclinical performance

Outcome Measures

Primary Outcomes (4)

  • The ease of insertion of supraglottic airway devices

    The ease of insertion was evaluated using a 3-point scale: 1=easy (the device was placed successfully on the first attempt without resistance and without the need for additional maneuvers); 2=difficult (the device was placed on the first attempt with slight resistance, requiring either upward or downward movement of the device or lifting of the chin); or 3=very difficult (placement was only achieved on the second attempt despite maneuvers).

    intraoperative period

  • The time of insertion of supraglottic airway devices

    The placement time for the supraglottic airway devices is defined as the duration between the removal of the face mask and the observation of the first end tidal carbon dioxide waveform

    intraoperative period

  • The ease of gastric tube insertion of supraglottic airway devices

    The number of attempts and the ease of gastric tube insertion were assessed also using a 3-point scale after lubricating the gastric tube and advancing it through the gastric channel following SGAD placement: 1=first attempt (successful insertion on the first try); 2=second attempt (successful insertion on the second try); or 3=failure (insertion was not successful

    intraoperative period

  • oropharyngeal leak pressure of supraglottic airway devices

    Oropharyngeal leak pressure (OLP) was measured during the operation after the SGAD was properly positioned. Measurements were taken at 15-minute intervals throughout the procedure and at the end of the surgery, just before removing the SGAD. OLP was determined by observing the pressure at which air leaked from the mouth, utilizing a fixed fresh gas flow of 5 L/min. The expiratory (APL) valve was closed at 30 cmH2O to ensure that the peak airway pressure did not exceed 40 cmH2O. The assessment of OLP used a five-point scale: 1=excellent (no air leak at 30 cmH2O); 2=good (air leak at 18-20 cmH2O); 3=moderate (air leak at 10-16 cmH2O); 4=poor (air leak at ≤ 8 cmH2O); and 5=placement/ventilation failure

    intraoperative period

Secondary Outcomes (3)

  • postoperative pharyngolaryngeal complications

    up to postoperative 12 hour

  • postoperative pharyngolaryngeal complications

    up to postoperative 12 hour

  • postoperative pharyngolaryngeal complications

    up to postoperative 12 hour

Study Arms (2)

group ı-gel

The patients participating in the study were randomly assigned to two groups

Other: Clinical performance

group lma-s

The patients participating in the study were randomly assigned to two groups

Other: Clinical performance

Interventions

Supraglottic airway devices were evaluated for ease of insertion, time of insertion, success rate at first attempt, number of attempts, ease of gastric tube insertion, oropharyngeal leak pressure, and intraoperative and postoperative complications

group lma-sgroup ı-gel

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients aged 65 and older, who all had an American Society of Anesthesiologists (ASA) score of I-III, and who were scheduled for elective urological surgery under general anesthesia were prospectively recruited.

You may qualify if:

  • ≥65 age patients
  • American Society of Anesthesiologists (ASA) score of I-III
  • elective urological surgery

You may not qualify if:

  • emergency surgery,
  • unstable vital signs
  • history of or suspicion of a difficult airway
  • preoperative sore throat, or a high risk of aspiration
  • body mass index ≥ 35 kg/m²
  • gastroesophageal reflux
  • hiatal hernia
  • diabetic gastroparesis or a history of medications affecting gastrointestinal motility
  • patients with a high risk of respiratory complications, such as those with asthma, chronic obstructive pulmonary disease, or recent pneumonia
  • abnormalities of the oral cavity or pharynx,
  • cervical spine issues,
  • communication difficulties
  • scheduled for surgeries lasting ≥ 90 minutes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University Medical Faculty Department of Anesthesiology and Reanimation

Izmir, Bornova, 35100, Turkey (Türkiye)

Location

Related Publications (2)

  • Kim EM, Kim MS, Koo BN, Lee JR, Lee YS, Lee JH. Clinical efficacy of the classic laryngeal mask airway in elderly patients: a comparison with young adult patients. Korean J Anesthesiol. 2015 Dec;68(6):568-74. doi: 10.4097/kjae.2015.68.6.568. Epub 2015 Nov 25.

  • Chen X, Jiao J, Cong X, Liu L, Wu X. A comparison of the performance of the I-gel vs. the LMA-Sduring anesthesia: a meta-analysis of randomized controlled trials. PLoS One. 2013 Aug 12;8(8):e71910. doi: 10.1371/journal.pone.0071910. eCollection 2013.

Study Officials

  • NURSEN KARACA, MEDİCAL DOCTOR

    Ege University Medical Faculty, Department of Anesthesiology and Reanimation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 13, 2025

First Posted

February 27, 2025

Study Start

April 17, 2019

Primary Completion

April 17, 2020

Study Completion

May 17, 2020

Last Updated

February 27, 2025

Record last verified: 2025-02

Locations